Literature DB >> 4212999

Clonazepam in the treatment of epilepsy.

C Y Huang, J G McLeod, D Sampson, W J Hensley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4212999     DOI： 10.5694/j.1326-5377.1974.tb93563.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Influence of phenobarbital on the disposition of clonazepam and antipyrine in the dog.

Authors:  I Bekersky; A C Maggio; V Mattaliano; H G Boxenbaum; D E Maynard; P D Cohn; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1976-11       Impact factor: 9.546

5.  Treatment of epilepsy with clonazepam and its effect on other anticonvulsants.

Authors:  R N Nanda; R H Johnson; H J Keogh; D G Lambie; I D Melville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-06       Impact factor: 10.154

Review 6.  Drug treatment of epilepsy. Outlines, criticism and perspectives.

Authors:  E Beghi; R Di Mascio; G Tognoni
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

7.  Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions.

Authors:  Arne Reimers; Eirik Skogvoll; Janne Kutschera Sund; Olav Spigset
Journal:  Eur J Clin Pharmacol       Date:  2007-05-12       Impact factor: 3.064
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.